Skip to main content
HomeDrug Comparisons
Drug bottle and Pill

Compare Koselugo vs. Gomekli

Head-to-head comparisons of medication uses, side effects, warnings, and more.

  • Koselugo (selumetinib)
    Gomekli (mirdametinib)
  • Koselugo (selumetinib)
    Gomekli (mirdametinib)

  • Summary of Koselugo vs. Gomekli

    Summary for MEK inhibitor
    Prescription only

    Koselugo (selumetinib) is a targeted therapy that works as a MEK inhibitor. It treats certain tumors caused by a genetic condition called neurofibromatosis type 1 (NF1). More specifically, it’s for adults and children 1 year and older with NF1 who have plexiform neurofibromas (PN), or small tumors around nerve tissue. Koselugo (selumetinib) comes as capsules and oral granules that are taken by mouth twice a day. But it can cause side effects like vomiting, diarrhea, and rash.

    Summary for MEK inhibitor
    Prescription only

    Gomekli (mirdametinib) is an FDA‑approved medication for neurofibromatosis type 1 (NF1). It's used for people ages 2 years and up with NF1 who have tumors called plexiform neurofibromas (PN) that can't be fully removed with surgery. Gomekli (mirdametinib) works as a MEK inhibitor to shrink the tumors. It comes as capsules as well as tablets that can be swallowed or mixed in water. You take the medication by mouth twice a day for 21 days, then have 7 days off in a repeating 28‑day cycle. Common side effects include rash, diarrhea, and nausea.

  • Indications of Koselugo vs. Gomekli

    Indications for
    •Neurofibromatosis type 1 (NF1) with symptomatic plexiform neurofibromas (PN) that can’t be removed by surgery
    Indications for
    •Neurofibromatosis type 1 (NF1) with symptomatic plexiform neurofibromas (PN) that can’t be fully removed by surgery

  • Pros and Cons of Koselugo vs. Gomekli

    Pros and Const for MEK inhibitor
    Pros
    •Taken by mouth
    •Oral granules also available for people who can’t swallow pills whole
    •Can help shrink or keep NF1 PNs from growing when surgery can’t completely remove them
    Cons
    •Must take twice a day
    •Can cause rash, dry skin, and upset stomach
    •Need regular eye exams and heart checks for safety
    Pros and Const for MEK inhibitor
    Pros
    •Taken by mouth
    •Also available as tablets for oral suspension that can be dissolved in water if swallowing pills is hard
    •Can help shrink PN in many people with NF1
    Cons
    •Taken twice a day on a 3-weeks-on, 1-week-off schedule that you must follow closely
    •Often causes skin rash
    •Need regular eye exams and heart checks for safety

  • Common Side Effects of Koselugo vs. Gomekli

    Common Side Effects for

    Children:

    •Nausea
    •Vomiting
    •Diarrhea
    •Higher creatine phosphokinase levels
    •Dry skin
    •Acne-like rash
    •Nail infection
    •Fever

    Adults:

    •Rash
    •Acne-like rash
    •Diarrhea
    Common Side Effects for
    •Rash (82%)
    •Diarrhea (57%)
    •Higher creatine phosphokinase levels (57%)
    •Joint, muscle, or bone pain (41%)
    •Nausea (40%)
    •Vomiting (39%)
    •Higher triglyceride levels (37%)
    •Stomach pain (32%)
    •Lower hemoglobin levels (25%)

  • Warnings of Koselugo vs. Gomekli

    Common Side Effects for
    •Lower heart function
    •Eye problems
    •Diarrhea, nausea, vomiting, and mouth sores
    •Skin problems
    •Higher creatine phosphokinase levels
    •Higher vitamin E and bleeding risk (capsules only)
    •Harm to an unborn baby
    Common Side Effects for
    •Eye problems
    •Lower heart function
    •Skin reactions, including rash
    •Harm to an unborn baby

  • Prices with our coupons for Koselugo vs. Gomekli

    Learn more about Koselugo
    Learn more about Gomekli

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.